Koda Full Year 2025 Earnings: EPS: US$0.007 (vs US$0.054 loss in FY 2024)
Koda (SGX:BJZ) reported its Full Year 2025 results, achieving a revenue of US$52.7 million, a 16% increase from FY 2024. The company posted a net income of US$547,000, recovering from a US$4.52 million loss in the previous year, with an EPS of US$0.007 compared to a loss of US$0.054 in FY 2024. The profit margin improved to 1.0%. Despite these positive results, Koda has three warning signs in its investment analysis, two of which are potentially serious.
Koda (SGX:BJZ) Full Year 2025 Results
Key Financial Results
- Revenue: US$52.7m (up 16% from FY 2024).
- Net income: US$547.0k (up from US$4.52m loss in FY 2024).
- Profit margin: 1.0% (up from net loss in FY 2024). The move to profitability was driven by higher revenue.
- EPS: US$0.007 (up from US$0.054 loss in FY 2024).
AI is about to change healthcare. These 20 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10bn in marketcap - there is still time to get in early.
All figures shown in the chart above are for the trailing 12 month (TTM) period
Koda's share price is broadly unchanged from a week ago.
Risk Analysis
Be aware that Koda is showing 3 warning signs in our investment analysis and 2 of those are potentially serious...
